RJA
MWV

Raymond James & Associates’s MEADWESTVACO CORP MWV Stock Holding History

Raymond James & Associates’s Portfolio MWV Stock Details MWV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-212,015
Closed -$10M – 2470
2015
Q2 		$10M Buy
212,015
+15,832
+8% +$777K 0.04% 523
2015
Q1 		$9.78M Sell
196,183
-51,598
-21% -$2.57M 0.04% 456
2014
Q4 		$11M Sell
247,781
-1,003
-0.4% -$43.4K 0.05% 377
2014
Q3 		$10.2M Sell
248,784
-19,336
-7% -$827K 0.06% 353
2014
Q2 		$11.9M Sell
268,120
-45,247
-14% -$1.84M 0.07% 296
2014
Q1 		$11.8M Buy
313,367
+43,047
+16% +$1.57M 0.08% 274
2013
Q4 		$9.98M Buy
270,320
+24,727
+10% +$892K 0.07% 301
2013
Q3 		$9.43M Buy
245,593
+17,464
+8% +$643K 0.08% 278
2013
Q2 		$7.78M Buy
+228,129
New +$8.02M 0.07% 307

Other funds holding MWV

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
SB
Suntrust Banks Atlanta, Georgia $19.2B AUM 0.83% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Raymond James & Associates's MWV Position: Q3 2015 in Review

Raymond James & Associates sold out of MEADWESTVACO CORP (MWV) in Q3 2015, closing a stake of 212,015 shares — an estimated $10M sold.

Raymond James & Associates first reported a position in MWV in Q2 2013 and held it in 9 quarters. The position peaked at $11.9M in Q2 2014. 3 funds tracked by Wall St. Rank hold MWV as of Q3 2015.

  • Raymond James & Associates reported no remaining MEADWESTVACO CORP position as of Q3 2015 after selling out during the quarter.
  • Raymond James & Associates sold 212,015 MEADWESTVACO CORP shares in Q3 2015, an estimated $10M.
  • Raymond James & Associates first reported a position in MEADWESTVACO CORP in Q2 2013 and held it in 9 quarters.
  • Raymond James & Associates's MEADWESTVACO CORP position peaked at $11.9M in Q2 2014.
  • 3 funds tracked by Wall St. Rank held MEADWESTVACO CORP as of Q3 2015.

Based on Raymond James & Associates's 13F filing for Q3 2015, filed 13 Nov 2015.